283 related articles for article (PubMed ID: 22711296)
1. Achieving regio- and enantioselectivity of P450-catalyzed oxidative CH activation of small functionalized molecules by structure-guided directed evolution.
Agudo R; Roiban GD; Reetz MT
Chembiochem; 2012 Jul; 13(10):1465-73. PubMed ID: 22711296
[TBL] [Abstract][Full Text] [Related]
2. Evolving P450pyr Monooxygenase for Regio- and Stereoselective Hydroxylations.
Yang Y; Li Z
Chimia (Aarau); 2015; 69(3):136-41. PubMed ID: 26507217
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
Roiban GD; Agudo R; Reetz MT
Angew Chem Int Ed Engl; 2014 Aug; 53(33):8659-63. PubMed ID: 24590553
[TBL] [Abstract][Full Text] [Related]
4. Biocatalytic route to chiral acyloins: P450-catalyzed regio- and enantioselective α-hydroxylation of ketones.
Agudo R; Roiban GD; Lonsdale R; Ilie A; Reetz MT
J Org Chem; 2015 Jan; 80(2):950-6. PubMed ID: 25495724
[TBL] [Abstract][Full Text] [Related]
5. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
Peters MW; Meinhold P; Glieder A; Arnold FH
J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
[TBL] [Abstract][Full Text] [Related]
6. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution.
Kille S; Zilly FE; Acevedo JP; Reetz MT
Nat Chem; 2011 Aug; 3(9):738-43. PubMed ID: 21860465
[TBL] [Abstract][Full Text] [Related]
7. Expanding the toolbox of organic chemists: directed evolution of P450 monooxygenases as catalysts in regio- and stereoselective oxidative hydroxylation.
Roiban GD; Reetz MT
Chem Commun (Camb); 2015 Feb; 51(12):2208-24. PubMed ID: 25483552
[TBL] [Abstract][Full Text] [Related]
8. Engineering of recombinant E. coli cells co-expressing P450pyrTM monooxygenase and glucose dehydrogenase for highly regio- and stereoselective hydroxylation of alicycles with cofactor recycling.
Pham SQ; Gao P; Li Z
Biotechnol Bioeng; 2013 Feb; 110(2):363-73. PubMed ID: 22886996
[TBL] [Abstract][Full Text] [Related]
9. Inverting the enantioselectivity of P450pyr monooxygenase by directed evolution.
Tang WL; Li Z; Zhao H
Chem Commun (Camb); 2010 Aug; 46(30):5461-3. PubMed ID: 20520890
[TBL] [Abstract][Full Text] [Related]
10. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
11. Engineering of p450pyr hydroxylase for the highly regio- and enantioselective subterminal hydroxylation of alkanes.
Yang Y; Liu J; Li Z
Angew Chem Int Ed Engl; 2014 Mar; 53(12):3120-4. PubMed ID: 24554642
[TBL] [Abstract][Full Text] [Related]
12. CH-activating oxidative hydroxylation of 1-tetralones and related compounds with high regio- and stereoselectivity.
Roiban GD; Agudo R; Ilie A; Lonsdale R; Reetz MT
Chem Commun (Camb); 2014 Nov; 50(92):14310-3. PubMed ID: 25168091
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
14. An Enzymatic Route to α-Tocopherol Synthons: Aromatic Hydroxylation of Pseudocumene and Mesitylene with P450 BM3.
Dennig A; Weingartner AM; Kardashliev T; Müller CA; Tassano E; Schürmann M; Ruff AJ; Schwaneberg U
Chemistry; 2017 Dec; 23(71):17981-17991. PubMed ID: 28990705
[TBL] [Abstract][Full Text] [Related]
15. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
[TBL] [Abstract][Full Text] [Related]
16. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
[TBL] [Abstract][Full Text] [Related]
17. Oxygen activation by cytochrome P450BM-3: effects of mutating an active site acidic residue.
Yeom H; Sligar SG
Arch Biochem Biophys; 1997 Jan; 337(2):209-16. PubMed ID: 9016815
[TBL] [Abstract][Full Text] [Related]
18. Greatly reduced amino acid alphabets in directed evolution: making the right choice for saturation mutagenesis at homologous enzyme positions.
Reetz MT; Wu S
Chem Commun (Camb); 2008 Nov; (43):5499-501. PubMed ID: 18997931
[TBL] [Abstract][Full Text] [Related]
19. Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.
Ellis SW; Hayhurst GP; Lightfoot T; Smith G; Harlow J; Rowland-Yeo K; Larsson C; Mahling J; Lim CK; Wolf CR; Blackburn MG; Lennard MS; Tucker GT
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):565-71. PubMed ID: 10642515
[TBL] [Abstract][Full Text] [Related]
20. Improved product-per-glucose yields in P450-dependent propane biotransformations using engineered Escherichia coli.
Fasan R; Crook NC; Peters MW; Meinhold P; Buelter T; Landwehr M; Cirino PC; Arnold FH
Biotechnol Bioeng; 2011 Mar; 108(3):500-10. PubMed ID: 21246504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
